Biallelic inactivation of NF1 in a sporadic plexiform neurofibroma

被引:21
|
作者
Beert, Eline [1 ]
Brems, Hilde [1 ]
Renard, Marleen [2 ]
Ferreiro, Julio Finalet [1 ]
Melotte, Cindy [1 ]
Thoelen, Reinhilde [1 ]
De Wever, Ivo [3 ]
Sciot, Raf [4 ]
Legius, Eric [1 ]
Debiec-Rychter, Maria [1 ]
机构
[1] Katholieke Univ Leuven, Dept Human Genet, B-3000 Louvain, Belgium
[2] Univ Hosp Leuven, Dept Pediat, Louvain, Belgium
[3] Univ Hosp Leuven, Dept Surg Oncol, Louvain, Belgium
[4] Univ Hosp Leuven, Dept Pathol, Louvain, Belgium
来源
GENES CHROMOSOMES & CANCER | 2012年 / 51卷 / 09期
关键词
SEGMENTAL NEUROFIBROMATOSIS; SCHWANN-CELLS; TYPE-1; GENE; TUMORS;
D O I
10.1002/gcc.21969
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Plexiform neurofibromas are a major cause of morbidity in individuals with neurofibromatosis type 1 (NF1). Sporadically, these tumors appear as an isolated feature without other signs of NF1. A role for the NF1 gene in solitary plexiform neurofibromas has never been described. In this study, we report a 13-year-old boy who was diagnosed with a plexiform neurofibroma, without other NF1 diagnostic criteria. The tumor was partially resected and analyzed using different techniques: karyotyping, fluorescence in situ hybridization (FISH), and microarray comparative genomic hybridization (aCGH). Tumor Schwann cell culture and subsequent karyotyping showed a rearrangement involving chromosomes 1 and 17, namely an insertion of chromosomal bands 1p36-35 at 17q11.2. FISH demonstrated that the insertion interrupted the NF1 gene. In addition, a deletion was detected affecting the other NF1 allele. Whole-genome aCGH analysis of the resected tumor confirmed the presence of an 8.28 Mb deletion including the NF1 gene locus in similar to 15-20% of tumor cells. We conclude that biallelic NF1 inactivation was at the origin of the isolated plexiform neurofibroma in this patient. The insertion is most likely the first hit and the large deletion the second hit. (C) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:852 / 857
页数:6
相关论文
共 50 条
  • [11] A phase I study of thalidomide for the treatment of plexiform neurofibroma in patients with neurofibromatosis 1 (NF1)
    Gupta, A
    Cohen, BH
    Ruggieri, P
    Packer, RJ
    Phillips, P
    NEUROLOGY, 2000, 54 (07) : A12 - A13
  • [12] Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment
    Kershner, Leah J.
    Choi, Kwangmin
    Wu, Jianqiang
    Zhang, Xiyuan
    Perrino, Melissa
    Salomonis, Nathan
    Shern, Jack F.
    Ratner, Nancy
    JCI INSIGHT, 2022, 7 (18)
  • [13] Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
    Burnichon, Nelly
    Buffet, Alexandre
    Parfait, Beatrice
    Letouze, Eric
    Laurendeau, Ingrid
    Loriot, Celine
    Pasmant, Eric
    Abermil, Nassera
    Valeyrie-Allanore, Laurence
    Bertherat, Jerome
    Amar, Laurence
    Vidaud, Dominique
    Favier, Judith
    Gimenez-Roqueplo, Anne-Paule
    HUMAN MOLECULAR GENETICS, 2012, 21 (26) : 5397 - 5405
  • [14] NF1 plexiform neurofibroma growth rate by volumetric MRI - Relationship to age and body weight
    Dombi, E.
    Solomon, J.
    Gillespie, A. J.
    Fox, E.
    Balis, F. M.
    Patronas, N.
    Korf, B. R.
    Babovic-Vuksanovic, D.
    Packer, R. J.
    Belasco, J.
    Goldman, S.
    Jakacki, R.
    Kieran, M.
    Steinberg, S. M.
    Widemann, B. C.
    NEUROLOGY, 2007, 68 (09) : 643 - 647
  • [15] Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene
    Daschner, K
    Assum, G
    Eisenbarth, I
    Krone, W
    Hoffmeyer, S
    Wortmann, S
    Heymer, B
    KehrerSawatzki, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 234 (02) : 346 - 350
  • [16] The MEK inhibitor selumetinib reduces spinal neurofibroma burden in patients with NF1 and plexiform neurofibromas
    Jackson, Sadhana
    Baker, Eva H.
    Gross, Andrea M.
    Whitcomb, Patricia
    Baldwin, Andrea
    Derdak, Joanne
    Tibery, Cecilia
    Desanto, Jennifer
    Carbonell, Amanda
    Yohay, Kaleb
    O'Sullivan, Geraldine
    Chen, Alice P.
    Widemann, Brigitte C.
    Dombi, Eva
    NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [17] Giant cafe-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi in a patient with mosaic neurofibromatosis type 1 caused by biallelic NF1 microdeletions
    Hida, T.
    Idogawa, M.
    Okura, M.
    Sugita, S.
    Sugawara, T.
    Sasaki, Y.
    Tokino, T.
    Yamashita, T.
    Uhara, H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S263 - S263
  • [18] Pelvic plexiform neurofibroma during bowel/bladder dysfunction in an NF1 pediatric patient: A case report
    Allen, Ricci
    Epelman, Monica
    Cruz-Diaz, Omar
    Ellsworth, Pamela
    UROLOGY CASE REPORTS, 2021, 38
  • [19] Treatment for plexiform neurofibromas in patients with NF1
    Ardern-Holmes, Simone L.
    North, Kathryn N.
    LANCET ONCOLOGY, 2012, 13 (12): : 1175 - 1176
  • [20] Thyroid gland neurofibroma in a NF1 patient
    Anagnostouli, M
    Piperingos, G
    Yapijakis, C
    Gourtzelidis, P
    Balafouta, S
    Zournas, C
    Vassilopoulos, D
    Koutras, D
    Papageorgiou, C
    ACTA NEUROLOGICA SCANDINAVICA, 2002, 106 (01): : 58 - 61